Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by SizzlinSteakson Mar 29, 2018 5:52pm

132 Views

Post# 27805831

RE:RE:source shorts

As I suspected. So many make that mistake. The institutions will short the stock but will also cover on the way down which constitutes a lot of the "SHORT VOLUME". It is part of their game to walk it down so warrant holders sell to them at a cheaper price, assuming there are more shares being sold due to warrants, than there are buyers. Me thinks the warrant sellers are pretty much dried up by now. Good times ahead for ATE shareholders. We shall all be very rich in the next year or so.

Goaweigh wrote: That is the total short volume for that 2 week period, it is not the current short position.
The massive increase in LONG volume allowed the warrant holders to pre-sell against their warrants, technically they were short but in reality they were not.
Given recent events it's completely meaningless.

richardtrader wrote: https://shortdata.ca/?c=antibe-therapeutics%20inc.-short-sales&sym=ATE.V